Roberto Latini is Head of the Cardiovascular Clinical Pharmacology Laboratory at the Instituto di Ricerche Farmacologiche ‘Mario Negri’ in Milan, Italy. He is also Visiting Professor at the Department of Medicine of New York Medical College in Valhalla, New York, and a member of the Italian Study Group on Survival in Myocardial Infarction (GISSI) Co-ordinating Centre. Dr Latini has published numerous articles in peer-reviewed journals in the field of cardiology. He was part of the steering committee of GISSI 3 and the Randomised Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot. He is a member of the Steering Committee of the GISSI-HF trial, and co-chair of the GISSI-AF trial. In the Valsartan Heart Failure Trial (Val-HeFT) he acted as Co-Director of the neurohormone core laboratory and consulted for the steering committee of the trial.